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Abstract 
[lH]Hexachlorocyclohexane (HCH) was synthesized by 
chlorination of [lß]benzene prepared by catalytic tritiation of 
benzene with tritiated water. The isomers of HCH were 
separated by adsorption chromatography on silica gel. In 
order to determine the covalent binding to DNA, [lß]HCH 
was administered to male mice by oral gavage, and liver DNA 
was isolated via cbromatin. The specific radioactivity of the 
DNA was nonnalized by the dose administered and expressed 
in the molar units of the Covalent binding index, CBI = 
DNA damage/dose = (J.tmol bound HCH/mol DNA 
nucleotide)/(mmol HCH administered/kg body weight). CBI 
values of - 0.2 were found 10 h after the administration of 
alpha- and gamma-HCH. Enzymatic digestion of the DNA 
to the nucleosides and h.p.l.c. analysis revealed that - 400Jo 
of the radioactivity co-migrated with the natural nucleosides. 
At elution volumes known to contain the more lipophilic 
carcinogen-nucleoside adducts, - 10% of the radioactivity 
could be detected. The remaining 50% of th,e radioactivity 
eluted with the front, representing a mixture of oligonucleo-
tide-HCH adducts and/or hydrophilic degradation products 
which were strongly bot not covalently associated with intact 
DNA. Therefore, a true CBI of 0.02-0.1 must be expected 
both for alpha- and gamma-HCH. This CBI is by a factor of 
105 -106 below the value found with the strongest DNA-
binding carcinogens like aflatoxin B1 or dimethylnitrosamine 
and is unlikely to be decisive for the liver tumor induction in 
mice because of the foUowing additional findings: (i) 8oth 
isomers gave rise to similar Ievels of DNA darnage although 
the alpha-isomer is a much morepotent tumor inducer. This 
similarity was seen not only at the time of mäximum binding 
but up to 10 days after oral administration; (ü) three mouse 
strains with apparently different susceptibility to tumor in-
duction by gamma-HCH could not be distinguished with 
respect to DNA binding; (iü) the Ievei of DNA binding of 
alpha-HCH (CBI = 0.02-0.1) is more than three orders of 
magnitude lower than would be expected if the mechanism of 
tumor induction was by genotoxicity mediated by DNA-
binding. For a preliminary investigation on a potential 
stimulatory effect on liver DN A replication and ceU division, 
[l~]thymidine was admlnistered i.p. 3.5 h before sacrifice of 
the [lß]HCH-treated mice. The alpha-isomer was found to 
be more potent than the gamma-isomer in this respect. Taken 
together, our data allow the conclusion that the non-
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mutational processes must be more important for the carcino-
genicity of HCH. 
Introduction 
Hexachlorocyclohexane (HCH)* comprises of a group of 
isomers of which the gamma-isom~r, later called lindane, has 
very useful pesticidal activity (1). HCH have become of great 
public concem because the lindane batches used in the late 
forties contained appreciable concentrations of alpha- and 
beta-isomer. The alpha-isomer was found to induce liver 
tumors in rats and mice (2), the beta-isomer·was found to 
have very low biodegradability and to be deposited in animal 
fat. Although the lindane batches used since the fifties were at 
least 99% pure gamma-isomer, a new discussion arose from 
controversial findings of a liver tumor-inducing potential of 
lindane itself. 
Chemically-induced tumors are now thought to be the 
result of a DNA darnage succeeded by appropriate promotion 
(3). Most chemieals exert their activity by covalent interaction 
of a reactive metabolite with DNA in the target organ and are 
therefore called genotoxic. The metabolism of HCH involves 
the formation of oJefms (I) and a subsequent epoxidation 
could result in the generation of an electrophiJic species. 
Another group of tumor-enhancing agents, viz co-
carcinogens and promoters, do not themselves react with 
DNA but apparently modulate one or s.everal out of a variety 
of biochemical and biological steps related to the process of 
tumor formation. Such activities arealso d.iscussed for HCH. 
For instance, alpha-HCH was found to enhance the pro-
liferation of putative preneoplastic cells in rat liver (4), and all 
HCH isomers are known tobe inducers of drug-metabolizing 
enzymes (I), the alpha-isomer being more potent than lin-
dane. 
It was the aim of this study to provide more infonnation 
about the mechanism of tumor induction by HCH. Forthis 
reason it was examined whether the isomers of HCH can be 
metabolized in vivo to reactive metabolites able to reach and 
bind to liver DNA or whether the hepatocarcinogenicity is 
rather due to non-genotoxic effects. It seemed especially 
worthwhile to investigate whether the clear d.ifference bet-
ween the alpha- and the gamma·isomer with respect to 
biological effects and tumor induction .(2) was reflected in 
their ability to bind to DNA, and whether the apparent dif-
ference in susceptibility of different strains of mice to the 
carcinogenicity of gamma-HCH (5-7) can be based upon 
different Ievels of DNA bind.ing. 
Materials and Methods 
Chemieals and opparatus 
Reagents without specified distributor were of the highest purity available 
from Merck, Darmstadt, FRG. Hydroxylapatite {HA) (DNA-Grade, Bio-Gel 
HTP) was purchased from Bio-Rad, Richmond, CA, sodiurn dodecyl sulfate 
(SOS) from Sigma, St. Louis, MO, Nonidet P 40 (NP 40) and copper oxide 
(wire form) from BDH Chemieals Ltd., Poole, UK. Carrierfree PHJz and 
[lte}lhymidine with a sp. act. or 61 mCi/mmol were pwchased from lhe 
Radiochemical Centre, Amersharn, UK. Desoxyribonuclease I (E.C. 3.1.4.5.) 
from bovine panaeas, phosphodiesterase 1 (E.C. 3.1.4.1.) from Crotalus 
otrox venom and alkaHne phosphatase 111 (E.C. 3.1.3.1.) from Escherichio 
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coli were obtained from Sigma, St. Louis, MO. Dialysis tubing {Vasking type 
20/32, mol. wt. exclusion at 12 <XX>-14 (XX) daltons; diameter 17 mm) was 
from Union Carbide, Olicago, IL. The u.v.lamp was a Mineralight UVSL-58 
50W from Ultra-Violet Products Inc., San Gabriel, CA. 
Radioadivity measuremmts were canied out in 10 mllnsta-Gel (Packard 
Instruments, Downers Grove, IL) in a liquid scintillation counter, Packard Tri 
Carb 460 CD equipped with and calibrated for the automarle analysis of 
(3H]/[l'C] double-labeiJed samples. 
The isomeric and radioactive purities of the isomers of HCH were deter-
mined on a semipreparative gas chromatograph, Carlo Erba, Fractovap Linea 
2200 (Carlo Erba, Rodana, Milano, Italy). The mass spectrum of HCH was 
recorded at the Institute of Organic Otemistry, ETH Zürich, Switz.erland. 
The h.p.l.c. analysis of the nucleosides were perfonned on a semiprepara-
tive column (250 mm x 8 mm 10) equipped with two h.p.l.c. pumps, Kontron, 
LC Pump 410 (Kontron, Zürich, Switz.erland), controUed by a Kontron Pro-
grammer 200, for generating a linear gradient of two eluants. 
Synthesis of C'HJHCH 
[lH]Benzene was prepared by catalytic exchange tritiation of benzene on a 
high-varuum line. [lH]p derived from combusting 8.8 Ci carrier-free [lH]z 
at 600°C over 30 g copper oxide (wire form) was trapped under high vacuum 
in 250 "I tritluoroacetic acid cooled with liquid nitrogen. This mixture was 
lyoph.iliz.ed into a break-seal ampoule containing SOO ~Li (430 mg, 5.5 mmol) 
benzene and 10 mg Platinum Black. The sealed ampoule was incubated for 6 
days at I00°C. 
PHJHCH was synthesized by chlorination of [3H]benzene (8). 16.5 mmol 
chlorine gas were generated from Oxidation of 33 mmol silver chloride with 
12 g potassium dichromate in 100 ml concentrated sulfuric acid and trapped 
by cooling with liquid nitrogen. The [lH]benzene and chlorine were lyophiliz-
ed into a 2S ml quartz round-bottom flask prefilled with 5 m1 carbon tetra-
chloride. The mixturewas kept at - 2S°C to - 30°C for 2 h under irradiation 
at 254 nm. Solvent and unreacted benzene were distilled off and the residue 
containing - 500lo of the radioactivity was extracted with petroleum ether 
{30-4.S°C boiling point) to bring the alpha-, gamma-, delta· and epsilon 
isomers into solution. The specific radioactivity of HCH was calculated from 
results derived in preliminary synthesis with a trace arnount of radioactivity 
and was found to be - 1 Ci/mmol. The products were identified as HCH by 
mass spectrometry. The isomers were separated by chromatography on silica 
gel 60 aecording to Granger and Zwilling (9). The radiochemical purity of the 
isolated isomers was > 99Cifo, the isomeric purities were checked by semi-
preparative gas chromatography. Column: OV 17, 20'/o methylphenylsilicone, 
200 cm; column temperature: 175°C; injection temperature: 210°C, Nr 
pressure: 0.9 kglcmZ) and was found tobe 98% (alpha-HCH). 92% (gamma-
HCH; 8% epsilon-HCH) and 95% (delta·HCH; S% epsilson-HCH). Beta-
HCH was prepared by recrystallisation from a chlorofonn extract of the 
residue. The radiochemical purity was > 99%, the isomeric purity was 96% 
(4% epsilon-HCH). 
Animals and treatments 
Young adult male rnice of the strains NMRI, CFI, and C6B3FI with 
weights ranging from 25 g to 40 g were obtained from Cdamerck, Ingelheim, 
FRG. Labaratory chow (No. 21-343-7, Klingenthai MOhle AG, Basel, 
Switzerland) and tap water wer-e provided ad libitum for one week for ac-
climatisation. Administrations of HCH were carried out between 9.00 and 
10.00 a.m. by oral gavage in polyethylene glycol 300 containing 5% ethanol. 
The animals rec:eived an i.p. injection of 5 -IS "Ci [14C]thymidine in 0.9% 
Naa 6.5 h later and were killed after another 3.5 h. For the determination of 
the time depmdence of the DNA binding, the animals did not receive 
[l4CJthymidine and were saaificed I, 3, 5 and 10 days after the [3H)HCH ad-
rninistralion. 
Isolation of DNA and chromatin protein 
Isolation of chromatin. {In the cold) AnimaJs were bled by open heart 
puncture under ether anaesthesia. The livers were exised. minced and 
homogenized in a tetlon Potter-Eivehjem-type homogeniz.er in 3-4 volumes 
15 mM NaCI, 10 mM EDTA, 10 mM Tris!HO pH 7.8. Crude clrromatin 
was prepared according to Yaneva and Dessev (10) with some modifications. 
After adding a solution of 2Cifo (v/v) of the non-ionic detergent Nonidet P 40 
up to a final concentration of 0.2% (v/v) the samples were incubated at 4°C 
for 15 rnin. Chromatin was precipitated at 700 g for 5 min. The pellet was 
washed once with 75 rnM NaCI, 10 mM EDTA, 10 mM Tris/HO pH 7.8 
and centrifuged for S min at 3500 g. This pdlet contained about 2-3 mg 
DNA and 20-30 mg protein/g liver. 
Isolation oj DNA. (Room temperature) DNA was isolated from chromatin 
according to Markov and lvanov (11) with some modifications. The 
chromatinpellet was suspended in 25 mllysing medium (8 M urea, 0.2A M 
sodium phosphate buffer pH 6.8, 10 mM EDTA, 1% (w/v) SOS) and 
homogenized on a Waring biender in a rustom-made air-tight aluminium 
1268 
vessel (46 mm diameter, 28 mm high) run at high speed for 30 s and then 
cooled in cold ethanol (- 40"Q for J 5 s. The blending<Ooling procedure was 
repeated 4 times. After cautious transfer into a 50 ml polypropylene cen· 
trifuge tube the foam was broken by centrifugation for 3 min at 1000 g. 10 ml 
CIP (480 m1 chlorofonn, 20 .mJ isoamyl alcohol, ftlled up to I Iiter under stir-
ring with warmed liquid phenol) was added and proteins were eruacted in the 
centrifuge tube under extensive shaking for 10 min on a shaking machine. The 
resulting suspension was separated into two layers by centrifugation for 
J S min at 20 (XX) g. The CIP phase was saved for protein isolation, the super· 
natant aqueous layer was first decanted and then pipetted into a new poly-
propylene centrifuge tube and was extracted once more with 10 m1 CIP. The 
aqueous solution was ~racted twice with 2S m1 ether in a 250 ml separating 
funnel for the removal of trace amounts of phenol, was left standing over-
night at room temperature and was applied to an HA column. Dry HA (I g/g 
Ii ver) of special batches tested for high absorptivity of DNA was suspended 
ovemight in fl.ltered MUP (8 M urea, 0.2A M sodium phosphate buffer pH 
6.8), the slurry was swirled gently and wa.S left untouched for 10 min. The ftne 
panides were decanted. The rema.ining slurry was poured into 2S x 120 mm 
glass colwnns and the MUP was Iet run off. The aqueou~ nucleic acid solution 
was loaded on the column and the elution was monitared at 260 nm. Proteins 
were washed from the column with ftltered MUP at a now rate of 1-2 
ml/min by gravity until the transmission had retumed to background value. 
To avoid a mixing of the eluants the column was Iet run dry before purging 
the urea from the column with two bed volumes 14 mM sodium phosphate 
buffer, pH 6.8. DNA was eluted with 0.48 M sodium phosphate buffer, pH 
6.8, and -20 ml of the DNA solution were collected. From here on, extreme 
caution is required not to use glassware, equipment or facilities which are also 
used for proc:edures involving high radioactivity Ievels. The sample was diafyz. 
ed at4°Cagainst 10 Iiter 0.2 M NaCI ovemight. DNAwas precipitated by ad· 
ding 2 volumes ethanol and keeping at - 20°C for at least 12 h. The DNA 
was centrifuged for 20 min at 1000 g, the supematant was decanted and DNA 
was dried in vacuo for 2-3 h. The highly purified DNA was dissolved in 
10 mM MgCI21 10 mM Tris/HCI, pH 7.0. The amount of DNA was deter· 
mined on the basis of an absorbance of 20 at 260 nm for a solution of I mg 
DNA/ml. The yidd of DNA was - 1 mg/g liver limited by the use of sub-
optimal amounts of hydroxylapatite. The contamination of the DNA by pro-
tein was < 0.2% as derived from liver-DNA isolations from animals treated 
with L-[l'S]methionine or with L-(lfi]lysine. 
In a control experiment, DNA was isolaled from the pooled livers of two 
mice treated with [!H]HCH and [14CJthymidine. After each purification step 
DNA was precipitated from an aliquot of the aqueous solution by adding 2 
volumes ethanol at - 2D°C. After a centrifugation for 20 min at 1000 g, DNA 
was dried in vacuo and dissolved in deionized water. The amount of protein 
contaminating the crude DNA was measured by the method of Bensadoun 
and Weinstein (12), the amount of DNA was calculated from the specific 
[l'C]activity. The specific [lH]activity of the DNA was calculated as (total 
(lH]activity - (lH)activity of protein)/amount of DNA. 
Isolation of chromatin protein. I ml of the ftrst CIP extract from a DNA 
isolation of 10 g liver was shaken with -5 ml I O!o SOS in 14 mM sodium 
phosphate buffer, pH 6.8. Protein was precipitated with 25cmJ acetone and 
washed S times by redissolving in 2 ml I% SOS and acetone precipitation. 
The fmal protein sample in I% SOS was diluted with water to 0.1 DJo SOS, was 
precipitated by the addition of 2 volumes acetone and was stored at - 20"C 
ovemight. After a centrifugation at 300 g, the supematant was decanted and 
the protein residue was freed from acetonein vacuö for - 15 rnin. Protein was 
dissolved in 2 ml1% SOS in 14 mM sodium phosphate buffer, pH 6.8, over-
night and the solution was diluted with water to a ftnal concentration of 
1.4 mM sodium phosphate buffer. The amount of protein was determined 
with the Folin reagent. 1-4 ml containing -0.5 mg protein/ml were used for 
the liquid scintillation counting. 
Isolation of HCH metabolites 
The supernatant of the fii'St acetone precipitation of chromatin protein 
from lhe CIP pha.se was dried in vacuo. About 7507o of the radioactivity in the 
CIP phasc could be d.i.ssolved in 10 mM Mg01, 10 mM Tris!HO, pH 7.0 
and was loaded on a Lichrosorb RP18 column also used for the analysis of 
nudeosides by h.p.l.c. (see below). 
Water-soluble metabolites were obtained from the aqueous solution after 
the first CIP extraction of chromatin homogenate. DNA was precipita.ed by 
the addition of 2 volumes ethanol and the supematant was dried in vacuo. 
After dissolving the residue in 10 mM MgCiz 10 mM Tris/HCI, pH 7.0 the 
sample was analysed by h.p.l.c. 
H.p.l.c. analysis of the nudeosides 
DNA (1-2 mg/ml) in 10 mM MgCI2, 10 mM Tris/HCI, pH 7.0 was 
digested enzymatic:ally by the method described by King et al. (13). The 
resulting deoxynudeosides were separated by h.p.l.c. on a Uchrosorb RP1e 
column (250 nun x 8 mm) with a distilled water/methanol gradient of 
0-IOOJo methanol in 5 min, 10% methanol for S min and 10-100% 
methanol in 45 min at a flow rate of 3.5 mllmin. The opticaJ density of the 
eluate was recorded at 2S4 nm. Fractions of 2 min were collected and the scin-
tillation counting was performed after the addition of 10 rnl InSta-Gd. To 
avoid phase separation between the scintillation oocktail and the eluate, the 
fractions II - 14 were diluted with I rnl methanol. The retention times of the 
natural deoxynucleosides deoxycytosine, deoxyguanosine, thymidine and 
deo.xyadenosine were 9 min, 11.5 min, J3 min and 18 min, respectively. 
Recovery of radioactivity eluted, as a fraction of the injected ranged between 
90 and 110%, both for [lH] and [14C]. 
Ollcu/ations and statistia 
Determination of CBI. The radioactivity in the ONA after treatment of 
mice with [lH]HCH was expressed after nol111alimtion to the dose ad-
ministered: 
CBI' = d.p.m./mg ONA 
d.p.m.lkg body weight 
This value was converted to the molar units, 
CBI = fll!lOI chemicaJ bound/mol ONA nucleotide 
mrnol chemical appliedlkg body wetght 
acoording to CBI = CBI' x 309 x 10' on the basis of an average mol. wt. of 
309 glmol ONA nucleotides (14). 
Determination of Protein binding indices, PB/. The radioactivity in the 
chromatin protein after treatment of mice with [IH]HCH was expressed after 
normalization to the dose administered: 
PBI' = d.p.m./mg chromatin protein 
d.p.m.lkg body weight 
This val~e was converted to the molar units, 
PBI = ~ol chemicaJ bound/mol amino acid 
mmol chemical appliedlkg body weight 
acoording to PBI = PBI' x 110 x I ()Ion the basis of a mol. wt. of 110 glmo1 
for an average amino acid (IS). 
Determination of lncorporotion indices, II. The radioactivity in the ONA 
after treatment of mice with (lte]lhymidine was expressed after nonnalization 
to the dose administered: 
II, = d.p.m./mg ONA 
d.p.m.lkg body weight 
This value was converted to the molar units, 
11 _ pmol thymidine incofeärated/mol ONA nucleotide 
- mmol thymidine app ed/kg body weight 
according to II = II' x 309 x 10' on the basis of an average mol. wt. of 309 
g/mol ONA nucleotides. 
Calculation of standard devilltion. The total variability (statistical coun-
ting error and fluctuations due to vial, scintillation cocktail, countt'J', extemal 
radiation and composition of the sample) for ehe counting of a DNA sample 
containing little radioactivity was asswned to be equal to the variability of 
DNA samples isolated from untreated animals held together with the treated 
ones. On the basis of 33 background values compiled for 12 months, a respec-
tive standard deviation of 1.89 c.p.m. ( = I S.O.) was calculated. The stan-
dard deviation for a nct radioactivity in a vial therefore was Iaken as: 1 S.O. 
= .../(1.892 + (1.89/.../33'f) = 1.92 c.p.m. 
Limit of detection for radioactivity in nudeoside analysis. The total 
variability for each fraction of a h.p.l.c. analysiswas calculated on a Ievel of 1 
standard deviation (1 S.D.) from 5 nudeoside analyses of control ONA 
digests. The mean background value for each fraction was calculated wilh an 
accuracy of 1 5.0.1.../S. The maximum possible difference between sample 
and background radioactivity was dcterminfd on an interval of :t: 2 S.O. 
Results 
Comparison of isomers 
Table I compiles the radioactivities in mouse liver DNA 
isolated l 0 h after oral administration of a high radioactivity 
dose of gamma- and alpha-[lH]HCH. Under the assumption 
that the radioactivity is due to DNA-bound HCH molecules, 
the radioactivity can be expressed in the units of the CBI (14) 
after normalization to the dose administered. The last line of 
the Table I reveals the extremely low Ievel of apparent DNA 
binding (CBI around 0.2) and shows that the alpha-isomer 
did not give rise t~ a higher CBI than the gamma-isomer 
Covaleol blndlng of hexacblorocydobexaue isomers to DNA 
Table I. Specific activity of liver DNA of male NMRI mice, 10 b afteroral 
administration of gamma- and alpha-[lfi]HCH. 
Isomer gamma-HCH alpha-HCH 
Animal weight 
[g]; pool or 2 mice 66.2 70.2 68.2 72.7 66.7 70.3 
Dose 
[mglkgJ 13.0 12.0 12.0 8.S 6.2 7.8 
[mCilkg] 44.9 41.5 41.5 21.5 21.2 26.8 
ONA Sp. act. 
[d.p.m./mg] 89.9 77.1 75.8 39.4 30.6 25.7 
:t:1 s.o. :6.2 :t:7.3 :6.6 :t:4.8 :4.8 :4.1 
(CBI units] 0.28 0.26 0.25 0.2D 0.20 0.13 
±1 s.o. ±0.02 ±0.03 ±0.02 ±0.02 :0.03 :0.02 
Mean ±SEM 0.26 :f: 0.02 0.18 ± 0.03 
Tableß. Specific activity of liver ONA of male NMRI mice, 10 h afteroral 
administration of delta- and beta-[3H]HCH. 
Isomer delta-HCH beta-HCH 
Animal weight 67.1 64.7 66.3 62.5 
(g]; pool of 2 mice 
Dose 
[mglkg] 6.8 7.1 7.3 7.7 
[mCi/kg] 23.5 24.S 25.2 26.7 
ONA Sp. act. 
[d.p.m./mg] 34.3 21.4 <IS.l <17.4 
±I S.O. :12.6 ±4.9 
[CBI units] 0.2D 0.12 <0.08 <0.09 
±I S.O. :0.07 ±0.03 
Mean ±SEM 0.16 ± 0.06 <0.08 
although the former is a markedly more potent carcinogen. 
This is the rrrst indication to postulate that DNA binding can-
not be the decisive activity for the tumor-inducing potential 
of the HCH's. This hypothesis is also supported by the fm-
ding that the delta-isomer which has never been found to in-
duce tumors (16) also revealed a CBI of 0.16 (Table II). The 
beta-isomer did not give rise to detectable DNA radioactivity 
(Table II). 
In order to check whether a difference between the gamma-
and the alpha-isomer might be found at later times after the 
administration, the time dependence for the DNA binding 
was investigated. Figure 1 shows that the liver-DNA radio-
activity reached the same plateau Ievel of about CBI = 0.5 
after lO days. The time-dependent increase was faster in the 
frrst three days with the gamma-isomer, in accordance with 
the somewhat faster metabolism (17). lt was also checked 
whether the absorption from the gastro-intestinal tract of the 
relatively high doses of chemical was different for the two 
isomers. This was not the case because it was found that the 
whole liver contained 2.1% and 2.2DJo of the radioactivity 
dose of the gamma- and the alpha-isomer, respectively, one 
day after the oral administtation. 
Comparison of mouse strains 
An additional hint for whether DNA binding could be the 
main mode of tumorigenic action of HCH should be obtain-
ed from studies with strains of mice that are of apparently 
different susceptibility to liver tumor induction by the 
gamma-isomer. The results given in Table 111 show that the 
three strains used aU gave rise to similar CBI values although 
NMRI mice (CBI = 0.28) were found to be Jess susceptible to 
the tumorigenic action of gamrna-HCl than B6C3F1 mice 
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Frg. 1. Tune dependence of the binding of alpha- and gamma-['H]HCH to 
mouse liver DNA. Groups of male NMRI mice were given p.o. - 30 mCi 
[3H]HCH/kg and two animaJs were sacrificed each after 10 h (gamma-
[lH]HCH only), I, 3, 5 and 10 days. 
Table W. Specific activity of liver DNA of male NMRI, CFJ, and B6C3FI 
mice, 10 h afteroral administration of gamma-['H]HCH. 
Strain NMRI CFI B6C3FI 
Anima! weight 87.9 91.7 73.5 72.8 67.4 64.9 
[g]; pool of 2 mice 
Dose 
[mg/kg) 8.7 16.7 21.2 21.2 23.0 21.6 
[mCilkg) 30.0 57.7 73.0 73.0 79.3 74.3 
DNA Sp. act. 
[d.p.m./mg) 49.7 138.4 122.6 154.1 91.8 92.7 
:t:l s.o. :t: 11.7 :t:ll.6 :t: 11.5 :t:8.6 :t:9.6 :t:l2.8 
[CBI units] 0.23 0.33 0.23 0.29 0.16 0.17 
:t:1S.D. :t:O.OS :0.03 :0.02 :t:0.02 :t:0.02 ±0.02 
Mean :t: SEM 0.28 :i: 0.04 0.26 ± 0.02 0.17 :i: 0.02 
(CBI = 0.17) or CF1 mice (CBI = 0.26) (5-7). 
Contribution of contaminations to the DNA radioactivity 
It was assumed above that the DNA radioactivity was due 
entirely to DNA- HCH adducts. Other sources, such as 
biosynthetic incorporation of radiolabelled breakdown pro-
ducts of HCH entering the pool of DNA precursors, non-
covalently bound HCH metabolites or protein contamina-
tions might contribute all or a fraction of the radioactivity 
measured on the DNA. Any of these influences would make 
our argument for a non-mutagenic mode of action of HCH 
even stronger. A number of control experiments were per-
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Table IV. Specific activity of liver chromatin protein of male NMRI mice, 
10 h after oral administration of ('H]HCH. 
Isomer gamma-HCH alpha-HCH 
AnimaJ weight 66.2 70.2 68.2 72.7 66.7 70.3 
(g); pool of 2 mice 
Dose 
[mg/kg 13.0 12.0 12.0 8.S 6.2 7.8 
[mCilkg] 44.9 41.5 41.5 27.5 21.2 26.8 
Protein Sp. act. 
[d.p.m./mg) 6140 5170 3150 1374 1015 1126 
[PBJ units) 6.8 6.2 3.8 2.5 2.4 2.1 
Mean ±SEM 5.6 :t: 0.9 2.3 :t: 0.1 
fonned to investigate some of the above-mentioned contribu-
tions. 
Cantamination by protein-bound HCH. The data given 
in Table IV show that chromatin protein was also raclio-
labelled, 10 h after [lH]HCH administration. The specific ac-
tivity was 42- to 68-fold and 33- to 44-fold higher in protein as 
compared with DNA for the gamma-, and the alpha-isomer, 
respectively. Protein contamination of DNA was shown to be 
lower than 0.20/o as determined with radiolabelling of 
chromatin protein in vivo with PH]Iysine or [35S]methionine . 
Protein contaminations cannot therefore contribute substan-
tially to the radioactivity measured on the DNA. 
Cantamination of DNA by non-covalently bound HCH 
metabolites. The control experiment where DNA was 
precipitated at different steps of the purification procedure 
showed that neither ether extraction nor dialysis resulted in 
a reduction of the specific [3H]activity of DNA. This means 
that both lipophilic and hydrophilic metabolites had been 
removed completely from the DNA during the entire isolation 
procedure and that the DNA had been purified to constant 
specific activity. 
Nucleoside analysis 
Separation of the deoxynucleosides by h.p.l.c. after en-
zymatic digestion of üver DNA of alpha- and gamma-[3H]-
HCH treated NMRI rnice (10-h-point) revealed that 
- 30-400/o of the radioactivity eluted together with the op-
tical density of the natural deoxynucleosides (Figure 2). This 
radioactivity is therefore most probably due to biosynthetic 
incorporation of breakdown products, for instance tritiated 
water. At a later elution time, a small ( -100/o of the radio-
activity) but significant amount of radioactivity was detected. 
This is the region known to contain the more lipophiüc 
nucleoside-carcinogen adducts. The . fonnation of a 
nucleoside-HCH adduct therefore is highly probable. Up to 
SOOJo of the radioactivity of the DNA eluted in the frrst two 
fractions. This radioactivity can be due to DNA not com-
pletely degraded i.e., due to oligonucleotides which could still 
carry HCH adducts. 
The samerelative distribution of radioactivity among the 
three different elution regions was found with a duplicate 
DNA sample isolated 10 h after the administration of 
gamma-[lJI]-HCH and with a DNA pooled from 1-day, 
3-day, and 5-day mice. 
In order to further exclude the possibility that HCH 
metabolites non-covalently bound to DNA could be responsi-
ble for the presumed adduct peak in fraction 16 and 18 for 
the gamma- and the alpha-isomer, respectively, metabolites 
isolated from the liver of a gamma-[3H]HCH-treated mouse 
> 
.... 
-o ON 
a: 
J: 
M 
l 
5 
i\ i\ 
-
y-isomer 
o.-isomer 
10 15 2~ 
Froction Nr. 
25 
Fig. l. Radioactivity proflle of h.p.l.c. chromatograms of liver DNA of 
(IH)HCH-treated NMRI-mice, enzymatically digested to deoxynucleosides. 
The shaded area covers the range of the Iimit of detection for radioactivity in 
one fraction, calculated on an interval of : 2 S.O. Top, optical density pro-
file, representing the natural deoxyribonucleosides in the order dC, dG, dT, 
dA; Center, DNA taken from a NMRJ mouse, killed JO h after oral ad-
ministration of gamma-[3JI]HCH; Bottom, DNA taken from an NMRI 
mouse, killed 10 h afteroral administration of alpha-[3JI)HCH. Similar pro-
mes were obtained from a DNA pooled from 1-, 3-, and 5-<lay-mice (gamma-
isomer). 
were analysed on the same h.p.l.c. system as used for the 
nucleosides. Figure 3 shows that the hydrophilic metabolites 
eluted in the frrst three fractions. Since this is the region which 
also contained radioactivity in the h.p.l.c. analysis of the 
DNA nucleoside it canriot be excluded that such metabolites 
were closely but non-covalently associated with DNA. The 
association must have been so strong that the dialysis did not 
remove them and only upon enzymatic degradation of the 
DNA were they released. 
Lipophilic metabolites eluted at a retention time of 
- SO min. No radioactivity could be detected at retention 
times between 24 min and 48 min. These data indicate that 
the radioactivity peaks eluting after -35 min represent HCH-
deoxynucleoside-adducts and not metabolites set free during 
the hydrolysis of the DNA. 
True covalent DNA binding 
The control experiments described above have revealed 
that biosynthetic incorporation of radiolabel into DNA has 
taken place and that hydrophilic metabolites might have been 
strongly but non-covalently associated with DNA. For a 
calculation of a true CBI, these contributions have to be 
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Ffg. 3. H.p.l.c. analysis of metabolites of ganuna-[lH]HCH isolated from 
mouse liver. The shaded area covers the range of the Iimit of detection for 
radioactivity in one fraction, calculated on an interval of ±2 S.O. A, hydro-
philic fraction; 8, lipophilic fraction. 
deducted from the values given in Tables I- III. A reduction 
by a factor of -2 or 10 results, for the case where all early-
eluting radioactivity is regarded as oligonucleotide-HCH ad-
ducts or for the case where only the nucleoside-HCH adduct 
peak is considered. On a most conservative approach, 
therefore, a CBI of < 0.1 results. · 
Protein binding 
In our experiments on DNA binding we also detennined 
the Ievel of non-extractable radioactivity in chromatin pro-
tein. This was done in a first place in order to detennine 
whether contamination of DNA with protein of high specific 
radioactivity might simulate DNA binding. The protein-
binding values are also low on an absolute Ievel upon com-
parison with standard carcinogens (15), and, there was again 
no difference in protein binding between the two isomers 
(fable IV) or between the different strains of mice (fable V). 
Rate of DNA synthesis 
The animals received, 3.5 h before sacrifice, an i.p. injec-
tion of [14C]thymidine. The Ievel of [lfC]radioactivity on the 
DNA was then used as an index for DNA synthesis. The 
results summarized in Table VI show a tendency for the more 
potent alpha-isomer to induce a higher rate of DNA syn-
thesis. 1t should be pointed out that these data were obtained 
from the identical animals used for the detennination of 
DNA binding by [lH]HCH ('fable 1), where the alpha-isomer 
was even slightly less effective than the gamma-isomer. 
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Table V. Specific activity of Ii ver chromatin protein of male NMRI, CFl 
and 86C3Fl mice, 10 h after oral administration of ganuna-[lH]HCH. 
Strain NMRI CFl B6C3F1 
Animal weight 81.9 91.7 73.5 72.8 67.4 64.9 
[g); poo1 of 2 mice 
Dose 
[mg!kg) 8.7 16.7 21.2 21.2 23.0 21.6 
[mCi/kg) 30.0 51.1 73.0 73.0 79.3 74.3 
Protein Sp. act. 
[d.p.m./mg] 3300 7610 7910 9360 4560 4330 
[PBI units) 5.5 6.5 5.4 6.3 2.9 2.9 
Mean ::1: SEM 6.0 ::1: 0.5 5.8 ::1: o.s 2.9 ::1: 0.02 
Table VI. lncorporation of [14C]thymidine into liver DNA of male NMRI 
mice, 3.5 h after i.p. injection, and 10 h after oral application of PHJHCH. 
Isomer gamma-HCH alpha-HCH 
Animal weight 66.2 70.2 68.2 72.7 66.7 70.3 
(g}; pool of 2 mice 
Dose P4CTfdR 
[J.Lglkg] 40.0 30.5 40.0 36.8 35.5 28.8 
[pCi/kg} 10.0 7.6 10.0 9.2 8.9 7.2 
DNA Sp. act. 
[d.p.m./mg} 184 149 181 284 180 180 
lncorp. Index 2560 2710 2520 4280 2820 3460 
Mean ±SEM 2600 :t: 60 3SOO ::t: 400 
Discussion 
The previous section has provided good qualitative 
evidence for a DNA-HCH adduct. A comparison among 
strains and isomers makes it highly unlikely, however, that 
this type of genotoxic activity is the decisive mode of tumori-
genic action. In addition, a quantitative analysis of the Ievel 
of DNA binding favours a non-genotoxic mode of tumori-
genic action. A quantitative correlation of CBI versus 
carcinogenic potency expressed in TD50 units (i.e., the daily 
dose estimated to induce a turnor in 500Jo of the animals 
treated for life), has shown that CBI of the order of 103-lot 
are found with strong genotoxic carcinogens, of 100 for 
moderate carcinogens and of 1-10 for weak carcinogens 
(18). Since alpha-HCH has to be classified as a moderate 
turnor-inducing agent with an approximate TD50 value of 0.1 
mmol/kg/day for mause liver, a CBI for liver DNA of -102 
would be required if its mode of action was by DNA binding. 
The measured value of < 0.1 is one thousand times lower. 
Among the many possible mechanisms of tumorigenic ac-
tivity not related to DNA binding two aspects were amenable 
to an assay within the present experimental set-up. Frrstly, 
binding to protein and the concomitant cytotoxicity might be 
envisaged. Our results showed, however, that protein binding 
cannot be an important contribution to the proposed non-
mutagenic mode of turnor induction. 
Another possibility for a non-mutagenic mode of action, 
the Stimulation of cell division, was also tested simultaneously 
with the determination of DNA binding. These results gave 
some indication for a higher activity of the alpha-isomer 
although the experimental set-up was not ideal for the deter-
mination of this activity. It has been shown in rats that the in-
duction of DNA synthesis after administration of various 
tumor promoters is largest after a time perlad of - 20 h 
(19,20). In our experiments, we used mice and the interval 
was only 6.5 h. Therefore, the borderline effect observed 
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with the alpha-isomer might have become more pronounced 
if a time dependence had been investigated. Additional 
evidence along these lines is available from two-stage Iang-
term carcinogenicity studies with rats where it has been shown 
that alpha-HCH accelerated the manifestation of malignant 
liver tumors after initiation of the carcinogenic process by a 
single dose of diethylnitrosamine (21 ). 
Chemical carcinogens are normally divided into two large 
classes of mutagenic and non-mutagenic carcinogens (22). As 
suggested by Radman and Kinsella (23) there may not be a 
clear separation of these two groups of activities and it must 
be expected that there are carcinogens acting on more than 
only one Ievel. · 
With HCH, we are faced with a situation where aminute 
DNA binding was shown for the alpha- and the gamma-
isomer. Much additional information was given, however, to 
show that this activity cannot be responsible alone for the 
tumors induced and some hypotheses were presented and in 
part supported by experimental data. For a risk evaluation in 
man, a mutagenic risk by DNA binding after exposure to mg 
amounts of lindane seems negligible. Although species dif-
ferences with respect to the formation of reactive metabolites 
cannot be excluded we do have evidence that binding of 
gamma-HCH to liver DNA in the rat is sirnilar to the data ob-
tained in mice so that there are at least no indications for large 
species differences with respect to metabolism. For the more 
important events not related to DNA binding, an extra-
polation of animal data to man must be based upon the 
elucidation of the specific mechanism of tumor induction by 
HCH in the animal, and a test of whether similar activities are 
found in man at dose Ievels that are by orders of magnitude 
lower than those used in the Iang-term bioassays. 
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